Product Information
REPATHA 140 MG/ML SURECLICK is a brand product labeled by Amgen Inc., priced at $282.0209 per ML under NDC 72511039302. Its NADAC has been published 59 times since May 14, 2025.
Strength
140 mg/mL
Manufacturer
Amgen Inc.NDC
72511039302
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
EVOLOCUMABApproval Type
Biologic (BLA)
FDA Application
BLA125522On Market Since
11/24/2024
Pharmacological Classes
Price Statistics
The NADAC for REPATHA 140 MG/ML SURECLICK has been published 59 times since May 14, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $282.0209 per ML |
|---|---|
| All-time high | $282.0417 (Jun 10, 2026) |
| All-time low | $276.3138 (May 21, 2025) |
| 52-week high | $282.0417 |
| 52-week low | $276.3138 |
| Median price | $276.4739 |
| Average price | $278.6651 |
| Largest weekly change | +2.0% (Jan 14, 2026) |
| Weeks tracked | 59 |
| Tracking since | May 14, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPATHA 140 MG/ML SURECLICK?
The current National Average Drug Acquisition Cost (NADAC) for REPATHA 140 MG/ML SURECLICK, manufactured by Amgen Inc., is $282.0209 per ML (NDC 72511039302), effective Jun 24, 2026.
How has the price of REPATHA 140 MG/ML SURECLICK changed over time?
Over the history we have for it, the NADAC for REPATHA 140 MG/ML SURECLICK has held within roughly two percent of its current level. It has been tracked across 59 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for REPATHA 140 MG/ML SURECLICK?
Since May 14, 2025, the NADAC for REPATHA 140 MG/ML SURECLICK has ranged from a low of $276.3138 (May 21, 2025) to a high of $282.0417 (Jun 10, 2026), with a median of $276.4739 per ML.
Are there cheaper alternatives to REPATHA 140 MG/ML SURECLICK?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, REPATHA 140 MG/ML SYRINGE, is $281.6973 per ML — about 0% below REPATHA 140 MG/ML SURECLICK.
Who manufactures REPATHA 140 MG/ML SURECLICK?
REPATHA 140 MG/ML SURECLICK (NDC 72511039302) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification